Purple Biotech
Price & Volume
Stats
See more52W Range | $3.60-$29 |
Market Cap | $6.3M |
Shares Short | 7,972 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$59,000 |
Diluted EPS | -$54 |
News
See moreYahoo Finance • 2 months ago
Purple Biotech Regains Compliance with Nasdaq
Yahoo Finance • 5 months ago
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
Yahoo Finance • 6 months ago
Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 6 months ago
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
About
CEO | Mr. Gil Efron CPA, M.A. |
Address | 4 Oppenheimer Street, Rehovot, Israel, 7670104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |